CBDX — Curative Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Curative Biosciences, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	C2013 June 30th	2014 June 30th	C2015 June 30th	2016 June 30th	2017 June 30th
Period Length:	—	—	—	—	—
Source:	10-Q	10-K	10-Q	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.013	0.004	0.002	—	0
Total Inventory
Total Current Assets	0.064	0.004	0.002	—	0
Net Property, Plant And Equipment	0.051	0.011	0.008	0.005	0.002
Net Intangible Assets
Total Assets	0.119	0.016	0.01	0.005	0.002
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.671	0.381	0.706	0.62	0.633
Total Long Term Debt
Total Debt
Total Liabilities	0.671	0.381	0.706	0.62	0.633
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.552	-0.366	-0.696	-0.615	-0.631
Total Liabilities & Shareholders' Equity	0.119	0.016	0.01	0.005	0.002
Total Common Shares Outstanding